Pfizer and BioNTech to accelerate deliveries of Covid-19 vaccines to EU
Pfizer and BioNTech will bring forward some deliveries of their Covid-19 vaccine to the European Union to the second quarter.
AstraZeneca
11,988.00p
16:40 26/04/24
BIONTECH SP ADS
$87.21
10:59 26/04/24
Dow Jones I.A.
38,239.66
04:30 15/10/20
FTSE 100
8,139.83
17:09 26/04/24
FTSE 350
4,470.09
16:59 26/04/24
FTSE All-Share
4,423.59
17:14 26/04/24
Johnson & Johnson
$146.14
11:04 26/04/24
MODERNA
$107.97
12:59 26/04/24
Pfizer Inc.
$25.40
11:04 26/04/24
Pharmaceuticals & Biotechnology
22,773.26
16:59 26/04/24
According to EU head Ursula Von der Leyen, the firms will ship over 200m doses of the jab over the three months to June.
It was the first time that the bloc had disclosed the volume of shipments agreed with the two companies.
"This is very good news. It gives member states room to manoeuvre and possibly fill gaps in deliveries," von der Leyen said
Included in the second quarter volumes were an additional 10m doses which before had been expected to be delivered in the third and fourth quarters.
All told, the Commission had penciled-in deliveries of 300m doses from all vaccine makers with whom it had contracts for the second quarter combined.
The 300m figure included 55m doses from Johnson&Johnson and a further 35m from Moderna, according to German and Italian government planning documents, Reuters reported.
Yet during just the last week, AstraZeneca had announced it was aiming to deliver 70m doses in the second quarter.
That would be less than the 180m stipulated in its contracts but if they materialised would nevertheless push the bloc well above the 300m dose target.